XML 22 R4.htm IDEA: XBRL DOCUMENT v3.25.1
Consolidated Statements of Operations and Comprehensive Income (loss) - EUR (€)
€ in Thousands
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Revenue € 0 € 42
Cost of sales 0 70
Gross margin 0 (28)
Operating Expenses and Costs    
Selling and distribution expenses 678 1,110
General and administrative expenses 4,648 13,213
Research and development 1,118 16,136
(Gain)/Loss on deconsolidation/reconsolidation (62,554) 21,778
Other Operating income (398) (976)
Total Operating Expenses and Costs (56,508) 51,261
Income (Loss) from Operations 56,508 (51,289)
Other Income (Expenses)    
Income/(Loss) from changes in fair value of convertible note payable carried at fair value 8,923 5,404
Interest income 0 13
Interest expense 0 (55)
(Loss)/Gain on foreign currency translation (405) 220
Total Other Income (Expenses) 8,518 5,582
Net Income (Loss) € 65,026 € (45,707)
Net income (loss) per share to common shareholders:    
Basic (in EUR per share) € 44.86 € (31.99)
Diluted (in EUR per share) € 3.77 € (31.99)
Weighted average number of common shares:    
Basic (in shares) 1,449,485 1,428,858
Diluted (in shares) 17,254,895 1,428,858